首页> 外国专利> METHOD OF INDUCING CELL-MEDIATED PROTECTIVE IMMUNITY AGAINST HIV USING LOW DOSES OF IMMUNOGENS

METHOD OF INDUCING CELL-MEDIATED PROTECTIVE IMMUNITY AGAINST HIV USING LOW DOSES OF IMMUNOGENS

机译:低剂量免疫原诱导HIV介导的免疫保护性免疫的方法

摘要

A method and composition is disclosed for inducing a protective immunity against HIV by inoculation with immunogens in low doses that are sufficient to induce a sustained cellmediated response to HIV but below the amount necessary to induce an offsetting humoral response. The immunogens available for use in this method include attenuated forms of the HIV virus, subunits of the HIV virus, inactivated HIV virus and subinfectious doses of live HIV virus, all delivered at low doses these immunogens can be prepared with suitable carriers, adjuvants or diluents and administered either intramuscularly, mucosally (e.g., orally), intravenously or subcutaneously. The effectiveness of the initial dose of immunogen can be monitored for the presence of a sufficient cell-mediated response using a T-cell proliferation assay or an interleukin-2 assay and monitored for the lack of offsetting humoral response using commercially available ELISA assays for anti-HIV anibodies Depending upon the results of the cell-mediated response assays, supplementary or "booster" inoculations may be appropriate.
机译:公开了一种通过用低剂量的免疫原来诱导针对HIV的保护性免疫的方法和组合物,所述免疫原足以诱导对HIV的持续细胞介导的反应,但低于诱导抵消性体液反应所必需的量。可用于此方法的免疫原包括减毒形式的HIV病毒,HIV病毒的亚基,灭活的HIV病毒和亚感染剂量的活HIV病毒,所有这些均以低剂量递送,这些免疫原可用合适的载体,佐剂或稀释剂制备并且通过肌肉内,粘膜(例如口服),静脉内或皮下施用。可以使用T细胞增殖测定法或白介素2测定法监测是否有足够的细胞介导的反应,并使用市售ELISA法检测是否存在抵消的体液反应,从而监测免疫原初剂量的有效性。 -HIV抗体根据细胞介导的反应分析的结果,补充或“加强”接种可能是合适的。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号